Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Effects of age, BMI and sex on the glial cell marker TSPO - a multicentre [11C]PBR28 HRRT PET study.

Tuisku J, Plavén-Sigray P, Gaiser EC, Airas L, Al-Abdulrasul H, Brück A, Carson RE, Chen MK, Cosgrove KP, Ekblad L, Esterlis I, Farde L, Forsberg A, Halldin C, Helin S, Kosek E, Lekander M, Lindgren N, Marjamäki P, Rissanen E, Sucksdorff M, Varrone A; HRRT [11C ]PBR28 study group, Collste K, Gallezot JD, Hillmer A, Huang Y, Höglund CO, Johansson J, Jucaite A, Lampa J, Nabulsi N, Pittman B, Sandiego CM, Stenkrona P, Rinne J, Matuskey D, Cervenka S.

Eur J Nucl Med Mol Imaging. 2019 Jul 30. doi: 10.1007/s00259-019-04403-7. [Epub ahead of print]

PMID:
31363804
2.

Sex differences in amphetamine-induced dopamine release in the dorsolateral prefrontal cortex of tobacco smokers.

Zakiniaeiz Y, Hillmer AT, Matuskey D, Nabulsi N, Ropchan J, Mazure CM, Picciotto MR, Huang Y, McKee SA, Morris ED, Cosgrove KP.

Neuropsychopharmacology. 2019 Jul 3. doi: 10.1038/s41386-019-0456-y. [Epub ahead of print]

PMID:
31269510
3.

In vivo evidence for dysregulation of mGluR5 as a biomarker of suicidal ideation.

Davis MT, Hillmer A, Holmes SE, Pietrzak RH, DellaGioia N, Nabulsi N, Matuskey D, Angarita GA, Carson RE, Krystal JH, Esterlis I.

Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11490-11495. doi: 10.1073/pnas.1818871116. Epub 2019 May 13. Erratum in: Proc Natl Acad Sci U S A. 2019 Jun 17;:.

PMID:
31085640
4.

Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study.

Martinez D, Slifstein M, Matuskey D, Nabulsi N, Zheng MQ, Lin SF, Ropchan J, Urban N, Grassetti A, Chang D, Salling M, Foltin R, Carson RE, Huang Y.

Neuropsychopharmacology. 2019 Sep;44(10):1720-1727. doi: 10.1038/s41386-019-0398-4. Epub 2019 Apr 26.

PMID:
31026862
5.

Lower synaptic density is associated with depression severity and network alterations.

Holmes SE, Scheinost D, Finnema SJ, Naganawa M, Davis MT, DellaGioia N, Nabulsi N, Matuskey D, Angarita GA, Pietrzak RH, Duman RS, Sanacora G, Krystal JH, Carson RE, Esterlis I.

Nat Commun. 2019 Apr 4;10(1):1529. doi: 10.1038/s41467-019-09562-7.

6.

Social status and demographic effects of the kappa opioid receptor: a PET imaging study with a novel agonist radiotracer in healthy volunteers.

Matuskey D, Dias M, Naganawa M, Pittman B, Henry S, Li S, Gao H, Ropchan J, Nabulsi N, Carson RE, Huang Y.

Neuropsychopharmacology. 2019 Sep;44(10):1714-1719. doi: 10.1038/s41386-019-0379-7. Epub 2019 Mar 30.

PMID:
30928993
7.

A single-center, open-label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers.

Finnema SJ, Rossano S, Naganawa M, Henry S, Gao H, Pracitto R, Maguire RP, Mercier J, Kervyn S, Nicolas JM, Klitgaard H, DeBruyn S, Otoul C, Martin P, Muglia P, Matuskey D, Nabulsi NB, Huang Y, Kaminski RM, Hannestad J, Stockis A, Carson RE.

Epilepsia. 2019 May;60(5):958-967. doi: 10.1111/epi.14701. Epub 2019 Mar 29.

PMID:
30924924
8.

First in-human PET study and kinetic evaluation of [18F]AS2471907 for imaging 11β-hydroxysteroid dehydrogenase type 1.

Bhatt S, Nabulsi NB, Li S, Cai Z, Matuskey D, Bini J, Najafzadeh S, Kapinos M, Ropchan JR, Carson RE, Cosgrove KP, Huang Y, Hillmer AT.

J Cereb Blood Flow Metab. 2019 Mar 21:271678X19838633. doi: 10.1177/0271678X19838633. [Epub ahead of print]

PMID:
30895878
9.

Imaging the Enzyme 11β-Hydroxysteroid Dehydrogenase Type 1 with PET: Evaluation of the Novel Radiotracer 11C-AS2471907 in Human Brain.

Gallezot JD, Nabulsi N, Henry S, Pracitto R, Planeta B, Ropchan J, Lin SF, Labaree D, Kapinos M, Shirali A, Lara-Jaime T, Gao H, Matuskey D, Walzer M, Marek GJ, Bellaire S, Yuan N, Carson RE, Huang Y.

J Nucl Med. 2019 Aug;60(8):1140-1146. doi: 10.2967/jnumed.118.219766. Epub 2019 Mar 15.

PMID:
30877174
10.

Editorial.

Matuskey D.

Neurosci Lett. 2019 Jan 19;691:1-2. doi: 10.1016/j.neulet.2018.10.033. Epub 2018 Oct 18. No abstract available.

PMID:
30342079
11.

Positron emission tomography imaging of the γ-aminobutyric acid system.

Andersson JD, Matuskey D, Finnema SJ.

Neurosci Lett. 2019 Jan 19;691:35-43. doi: 10.1016/j.neulet.2018.08.010. Epub 2018 Aug 10. Review.

PMID:
30102960
12.

PET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseases.

Cai Z, Li S, Matuskey D, Nabulsi N, Huang Y.

Neurosci Lett. 2019 Jan 19;691:44-50. doi: 10.1016/j.neulet.2018.07.038. Epub 2018 Jul 31. Review.

PMID:
30075287
13.

Cerebellar and prefrontal cortical alterations in PTSD: structural and functional evidence.

Holmes SE, Scheinost D, DellaGioia N, Davis MT, Matuskey D, Pietrzak RH, Hampson M, Krystal JH, Esterlis I.

Chronic Stress (Thousand Oaks). 2018 Jan-Dec;2. doi: 10.1177/2470547018786390. Epub 2018 Jul 6.

14.

Age-Related Change in 5-HT6 Receptor Availability in Healthy Male Volunteers Measured with 11C-GSK215083 PET.

Radhakrishnan R, Nabulsi N, Gaiser E, Gallezot JD, Henry S, Planeta B, Lin SF, Ropchan J, Williams W, Morris E, D'Souza DC, Huang Y, Carson RE, Matuskey D.

J Nucl Med. 2018 Sep;59(9):1445-1450. doi: 10.2967/jnumed.117.206516. Epub 2018 Apr 6.

15.

Evaluation of (-)-[18 F]Flubatine-specific binding: Implications for reference region approaches.

Bhatt S, Hillmer AT, Nabulsi N, Matuskey D, Lim K, Lin SF, Esterlis I, Carson RE, Huang Y, Cosgrove KP.

Synapse. 2018 Mar;72(3). doi: 10.1002/syn.22016. Epub 2017 Nov 17.

16.

Partial-volume correction increases estimated dopamine D2-like receptor binding potential and reduces adult age differences.

Smith CT, Crawford JL, Dang LC, Seaman KL, San Juan MD, Vijay A, Katz DT, Matuskey D, Cowan RL, Morris ED, Zald DH, Samanez-Larkin GR.

J Cereb Blood Flow Metab. 2019 May;39(5):822-833. doi: 10.1177/0271678X17737693. Epub 2017 Nov 1.

17.

Metabotropic Glutamate Receptor 5 and Glutamate Involvement in Major Depressive Disorder: A Multimodal Imaging Study.

Abdallah CG, Hannestad J, Mason GF, Holmes SE, DellaGioia N, Sanacora G, Jiang L, Matuskey D, Satodiya R, Gasparini F, Lin X, Javitch J, Planeta B, Nabulsi N, Carson RE, Esterlis I.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Jul;2(5):449-456. doi: 10.1016/j.bpsc.2017.03.019. Epub 2017 Apr 6.

18.

The Effect of Treatment with Guanfacine, an Alpha2 Adrenergic Agonist, on Dopaminergic Tone in Tobacco Smokers: An [11C]FLB457 PET Study.

Sandiego CM, Matuskey D, Lavery M, McGovern E, Huang Y, Nabulsi N, Ropchan J, Picciotto MR, Morris ED, McKee SA, Cosgrove KP.

Neuropsychopharmacology. 2018 Apr;43(5):1052-1058. doi: 10.1038/npp.2017.223. Epub 2017 Sep 25.

19.

Multimodal Investigation of Network Level Effects Using Intrinsic Functional Connectivity, Anatomical Covariance, and Structure-to-Function Correlations in Unmedicated Major Depressive Disorder.

Scheinost D, Holmes SE, DellaGioia N, Schleifer C, Matuskey D, Abdallah CG, Hampson M, Krystal JH, Anticevic A, Esterlis I.

Neuropsychopharmacology. 2018 Apr;43(5):1119-1127. doi: 10.1038/npp.2017.229. Epub 2017 Sep 25.

20.

Kinetic evaluation and test-retest reproducibility of [11C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans.

Finnema SJ, Nabulsi NB, Mercier J, Lin SF, Chen MK, Matuskey D, Gallezot JD, Henry S, Hannestad J, Huang Y, Carson RE.

J Cereb Blood Flow Metab. 2018 Nov;38(11):2041-2052. doi: 10.1177/0271678X17724947. Epub 2017 Aug 9.

PMID:
28792356
21.

Altered metabotropic glutamate receptor 5 markers in PTSD: In vivo and postmortem evidence.

Holmes SE, Girgenti MJ, Davis MT, Pietrzak RH, DellaGioia N, Nabulsi N, Matuskey D, Southwick S, Duman RS, Carson RE, Krystal JH, Esterlis I; Traumatic Stress Brain Study Group.

Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8390-8395. doi: 10.1073/pnas.1701749114. Epub 2017 Jul 17. Erratum in: Proc Natl Acad Sci U S A. 2017 Sep 5;:.

22.

Preliminary evidence concerning the pattern and magnitude of cognitive dysfunction in major depressive disorder using cogstate measures.

Davis MT, DellaGioia N, Matuskey D, Harel B, Maruff P, Pietrzak RH, Esterlis I.

J Affect Disord. 2017 Aug 15;218:82-85. doi: 10.1016/j.jad.2017.04.064. Epub 2017 Apr 27.

23.

Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [11C]ABP688 and PET imaging study in depression.

Esterlis I, DellaGioia N, Pietrzak RH, Matuskey D, Nabulsi N, Abdallah CG, Yang J, Pittenger C, Sanacora G, Krystal JH, Parsey RV, Carson RE, DeLorenzo C.

Mol Psychiatry. 2018 Apr;23(4):824-832. doi: 10.1038/mp.2017.58. Epub 2017 Apr 11.

24.

Regional and source-based patterns of [11C]-(+)-PHNO binding potential reveal concurrent alterations in dopamine D2 and D3 receptor availability in cocaine-use disorder.

Worhunsky PD, Matuskey D, Gallezot JD, Gaiser EC, Nabulsi N, Angarita GA, Calhoun VD, Malison RT, Potenza MN, Carson RE.

Neuroimage. 2017 Mar 1;148:343-351. doi: 10.1016/j.neuroimage.2017.01.045. Epub 2017 Jan 19.

25.

Imaging synaptic density in the living human brain.

Finnema SJ, Nabulsi NB, Eid T, Detyniecki K, Lin SF, Chen MK, Dhaher R, Matuskey D, Baum E, Holden D, Spencer DD, Mercier J, Hannestad J, Huang Y, Carson RE.

Sci Transl Med. 2016 Jul 20;8(348):348ra96. doi: 10.1126/scitranslmed.aaf6667.

PMID:
27440727
26.

Elevated Dopamine D2/3 Receptor Availability in Obese Individuals: A PET Imaging Study with [11C](+)PHNO.

Gaiser EC, Gallezot JD, Worhunsky PD, Jastreboff AM, Pittman B, Kantrovitz L, Angarita GA, Cosgrove KP, Potenza MN, Malison RT, Carson RE, Matuskey D.

Neuropsychopharmacology. 2016 Dec;41(13):3042-3050. doi: 10.1038/npp.2016.115. Epub 2016 Jul 4.

27.

Age-related changes in binding of the D2/3 receptor radioligand [(11)C](+)PHNO in healthy volunteers.

Matuskey D, Worhunksy P, Correa E, Pittman B, Gallezot JD, Nabulsi N, Ropchan J, Sreeram V, Gudepu R, Gaiser E, Cosgrove K, Ding YS, Potenza MN, Huang Y, Malison RT, Carson RE.

Neuroimage. 2016 Apr 15;130:241-247. doi: 10.1016/j.neuroimage.2016.02.002. Epub 2016 Feb 11.

28.

Imaging robust microglial activation after lipopolysaccharide administration in humans with PET.

Sandiego CM, Gallezot JD, Pittman B, Nabulsi N, Lim K, Lin SF, Matuskey D, Lee JY, O'Connor KC, Huang Y, Carson RE, Hannestad J, Cosgrove KP.

Proc Natl Acad Sci U S A. 2015 Oct 6;112(40):12468-73. doi: 10.1073/pnas.1511003112. Epub 2015 Sep 18.

29.

A preliminary study of dopamine D2/3 receptor availability and social status in healthy and cocaine dependent humans imaged with [(11)C](+)PHNO.

Matuskey D, Gaiser EC, Gallezot JD, Angarita GA, Pittman B, Nabulsi N, Ropchan J, MaCleod P, Cosgrove KP, Ding YS, Potenza MN, Carson RE, Malison RT.

Drug Alcohol Depend. 2015 Sep 1;154:167-73. doi: 10.1016/j.drugalcdep.2015.06.039. Epub 2015 Jun 30.

30.

A case series on the heightened autonomic response due to guanfacine and amphetamine interaction.

Gaiser EC, Matuskey D, Perkins E, D'Amico C, Abdelghany O, McKee SA, Cosgrove KP.

J Clin Psychopharmacol. 2015 Apr;35(2):197-9. doi: 10.1097/JCP.0000000000000273. No abstract available.

31.

Memory reconsolidation for treatment-resistant aggression and self-injurious behaviors.

Matuskey D, Sondik T.

J Clin Psychopharmacol. 2015 Feb;35(1):104-5. doi: 10.1097/JCP.0000000000000264. No abstract available.

PMID:
25502487
32.

Test-retest reliability of the novel 5-HT1B receptor PET radioligand [11C]P943.

Saricicek A, Chen J, Planeta B, Ruf B, Subramanyam K, Maloney K, Matuskey D, Labaree D, Deserno L, Neumeister A, Krystal JH, Gallezot JD, Huang Y, Carson RE, Bhagwagar Z.

Eur J Nucl Med Mol Imaging. 2015 Mar;42(3):468-77. doi: 10.1007/s00259-014-2958-5. Epub 2014 Nov 27.

PMID:
25427881
33.

The effects of methylphenidate on resting-state striatal, thalamic and global functional connectivity in healthy adults.

Farr OM, Zhang S, Hu S, Matuskey D, Abdelghany O, Malison RT, Li CS.

Int J Neuropsychopharmacol. 2014 Aug;17(8):1177-91. doi: 10.1017/S1461145714000674. Epub 2014 May 13.

34.

Parametric Imaging and Test-Retest Variability of ¹¹C-(+)-PHNO Binding to D₂/D₃ Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET Scanner.

Gallezot JD, Zheng MQ, Lim K, Lin SF, Labaree D, Matuskey D, Huang Y, Ding YS, Carson RE, Malison RT.

J Nucl Med. 2014 Jun;55(6):960-6. doi: 10.2967/jnumed.113.132928. Epub 2014 Apr 14.

35.

Dopamine D₃ receptor alterations in cocaine-dependent humans imaged with [¹¹C](+)PHNO.

Matuskey D, Gallezot JD, Pittman B, Williams W, Wanyiri J, Gaiser E, Lee DE, Hannestad J, Lim K, Zheng MQ, Lin SF, Labaree D, Potenza MN, Carson RE, Malison RT, Ding YS.

Drug Alcohol Depend. 2014 Jun 1;139:100-5. doi: 10.1016/j.drugalcdep.2014.03.013. Epub 2014 Mar 20.

36.

Reductions in brain 5-HT1B receptor availability in primarily cocaine-dependent humans.

Matuskey D, Bhagwagar Z, Planeta B, Pittman B, Gallezot JD, Chen J, Wanyiri J, Najafzadeh S, Ropchan J, Geha P, Huang Y, Potenza MN, Neumeister A, Carson RE, Malison RT.

Biol Psychiatry. 2014 Nov 15;76(10):816-22. doi: 10.1016/j.biopsych.2013.11.022. Epub 2013 Nov 28.

37.

The effects of methylphenidate on cerebral activations to salient stimuli in healthy adults.

Farr OM, Hu S, Matuskey D, Zhang S, Abdelghany O, Li CS.

Exp Clin Psychopharmacol. 2014 Apr;22(2):154-65. doi: 10.1037/a0034465. Epub 2013 Nov 4.

38.

Methylphenidate remediates error-preceding activation of the default mode brain regions in cocaine-addicted individuals.

Matuskey D, Luo X, Zhang S, Morgan PT, Abdelghany O, Malison RT, Li CS.

Psychiatry Res. 2013 Nov 30;214(2):116-21. doi: 10.1016/j.pscychresns.2013.06.009. Epub 2013 Aug 23.

39.

Late-life onset bipolar disorder presenting as a case of pseudo-dementia: a case discussion and review of literature.

Banga A, Gyurmey T, Matuskey D, Connor DF, Kaplan RF, Steffens DC.

Yale J Biol Med. 2013 Jun 13;86(2):235-44. Print 2013 Jun. Review.

40.

Gray matter volume correlates of global positive alcohol expectancy in non-dependent adult drinkers.

Ide JS, Zhang S, Hu S, Matuskey D, Bednarski SR, Erdman E, Farr OM, Li CS.

Addict Biol. 2014 Sep;19(5):895-906. doi: 10.1111/adb.12046. Epub 2013 Mar 6.

41.

A single-day paradigm of self-regulated human cocaine administration.

Matuskey D, Pittman B, Chen JI, Wanyiri J, Nadim H, Jatlow P, Gueorguieva R, Potenza MN, Morgan PT, Bhagwagar Z, Malison RT.

Pharmacol Biochem Behav. 2012 Nov;103(1):95-101.

42.

Age effects on serotonin receptor 1B as assessed by PET.

Matuskey D, Pittman B, Planeta-Wilson B, Walderhaug E, Henry S, Gallezot JD, Nabulsi N, Ding YS, Bhagwagar Z, Malison R, Carson RE, Neumeister A.

J Nucl Med. 2012 Sep;53(9):1411-4. doi: 10.2967/jnumed.112.103598. Epub 2012 Jul 31.

43.

Prefrontal cortical response to emotional faces in individuals with major depressive disorder in remission.

Kerestes R, Bhagwagar Z, Nathan PJ, Meda SA, Ladouceur CD, Maloney K, Matuskey D, Ruf B, Saricicek A, Wang F, Pearlson GD, Phillips ML, Blumberg HP.

Psychiatry Res. 2012 Apr 30;202(1):30-7. doi: 10.1016/j.pscychresns.2011.11.004. Epub 2012 May 16.

44.

A multistudy analysis of the effects of early cocaine abstinence on sleep.

Matuskey D, Pittman B, Forselius E, Malison RT, Morgan PT.

Drug Alcohol Depend. 2011 May 1;115(1-2):62-6. doi: 10.1016/j.drugalcdep.2010.10.015. Epub 2010 Dec 8.

45.

Biological markers of the effects of intravenous methylphenidate on improving inhibitory control in cocaine-dependent patients.

Li CS, Morgan PT, Matuskey D, Abdelghany O, Luo X, Chang JL, Rounsaville BJ, Ding YS, Malison RT.

Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14455-9. doi: 10.1073/pnas.1002467107. Epub 2010 Jul 26.

Supplemental Content

Loading ...
Support Center